3 options
Polysaccharide-Based Biomaterials : Delivery of Therapeutics and Biomedical Applications / Sougata Jana, Subrata Jana, and Abraham J. Domb.
- Format:
- Book
- Author/Creator:
- Jana, Sougata, author.
- Jana, Subrata, author.
- Domb, A. J. (Abraham J.), author.
- Series:
- ISSN
- Issn Series
- Language:
- English
- Subjects (All):
- Polysaccharides--Biotechnology.
- Polysaccharides.
- Biomedical materials.
- Physical Description:
- 1 online resource (610 pages)
- Edition:
- First edition.
- Place of Publication:
- London, England : Royal Society of Chemistry, [2023]
- Summary:
- With contributions from around the world, the editors have pulled together a tightly curated set of chapters which showcase how polysaccharide-based materials are employed in a range of biomedical systems.
- Contents:
- Intro
- Title
- Copyright
- Contents
- Chapter 1 Polysaccharide-based Biomaterials: Overview
- 1.1 Introduction
- 1.2 Cellulose
- 1.3 Chitosan
- 1.4 Modifications
- 1.5 Hyaluronic Acid
- 1.6 Dextran
- 1.7 Alginates
- 1.8 Pullulan
- 1.9 Chondroitin Sulfate
- 1.10 Conclusion
- References
- Chapter 2 Recent Approaches in Alginate-based Carriers for Delivery of Therapeutics and Biomedicine
- 2.1 Introduction
- 2.2 Alginate
- 2.2.1 Alginate: Chemical Structure and Characterization
- 2.2.2 Extraction of Alginate from Brown Seaweed Algae
- 2.3 Alginate-based Colloidal Systems
- 2.3.1 Alginate in Different Colloidal Systems
- 2.4 Alginate-based Carrier Applications in Delivery Systems and Biomedicine
- 2.4.1 Therapeutic Applications
- 2.4.2 Drug-controlled Release Systems
- 2.4.3 Biomedical Applications
- 2.5 Conclusions
- Acknowledgements
- Chapter 3 Alginate-based Carriers for Transdermal Drug Delivery
- 3.1 Introduction
- 3.2 Alginate: Sources, Physicochemical, and Biological Properties
- 3.2.1 Sources of Alginates
- 3.2.2 Physicochemical Properties
- 3.2.3 Biological Properties of Alginates
- 3.3 Preparations of Different Alginate-based Transdermal Systems
- 3.3.1 Alginate Films
- 3.3.2 Alginate-based Microneedles for Transdermal Drug Delivery
- 3.3.3 Alginate-based Electroresponsive Transdermal Drug Delivery System
- 3.4 Drug Delivery Application of Alginate Based Transdermal Carriers
- 3.4.1 Delivery of Antidiabetic Agents
- 3.4.2 Delivery of Anticancer Agents
- 3.4.3 Delivery of Anti-inflammatory Agents
- 3.4.4 Delivery of Antibiotics
- 3.4.5 Delivery of Antihypertensive Agents
- 3.4.6 Delivery of Antifungal Agents
- 3.4.7 Delivery of Antimicrobial Agents
- 3.4.8 Delivery of Antioxidants
- 3.4.9 Delivery of Anti-alopecia Agents
- 3.4.10 Miscellaneous
- 3.5 Conclusion
- References.
- Chapter 4 Chitosan-based Nanocarriers for Drug Delivery: Advances and Challenges
- 4.1 Introduction
- 4.2 Chitosan-based Drug Delivery Nanocarriers
- 4.2.1 Nanoparticles
- 4.2.2 Nanogels
- 4.2.3 Nanomicelles
- 4.2.4 Physicochemical Characterization of Nanospheres, Nanocapsules, and Nanogels
- 4.2.5 Nanofibers
- 4.3 Summary and Future Perspectives
- Abbreviations
- Chapter 5 Hyaluronic Acid in Drug Delivery
- 5.1 Introduction
- 5.1.1 Properties
- 5.1.2 Synthesis and Degradation
- 5.2 Application of Hyaluronic Acid in Drug Delivery Systems
- 5.2.1 HA in Parenteral Delivery
- 5.2.2 HA in Pulmonary Delivery
- 5.2.3 HA in Ocular Delivery
- 5.2.4 HA in Nasal Delivery
- 5.2.5 HA in Oral Delivery
- 5.2.6 HA in Vaginal Delivery
- 5.2.7 HA in Topical Delivery
- 5.2.8 HA in Tissue and Regenerative Medicine
- 5.2.9 HA in Anti-cancer Drug Delivery Systems
- 5.2.10 HA in Protein and Peptide Delivery
- 5.2.11 HA in Targeted Drug Delivery Systems
- 5.2.12 HA in Self-assembling Systems
- 5.3 Application of Hyaluronic Acid in Gene Delivery Systems
- 5.4 Application of Hyaluronic Acid in Imaging
- 5.4.1 Fluorescence Imaging
- 5.4.2 Magnetic Resonance Imaging
- 5.4.3 Theranostic Applications
- 5.5 Challenges and Opportunities
- 5.6 Conclusion
- Chapter 6 Dextran in the Delivery of Therapeutics: Chronicle of the Journey from Preclinical to Clinical Trials
- 6.1 Introduction
- 6.2 Dextran: An Extraordinary 'Slime' from the Bounty of Nature
- 6.2.1 Chemistry of Dextran
- 6.2.2 Physicochemical Properties of Dextran That Contribute to Its Superior Carrier Status
- 6.2.3 Methods of Synthesis
- 6.3 Preclinical Success Stories
- 6.4 Clinical Trials of Dextran as a Carrier
- 6.5 Future Perspectives
- 6.6 Conclusion
- Chapter 7 Guar Gum-based Biomaterials in the Delivery of Therapeutics
- 7.1 Introduction
- 7.1.1 Gums/Polysaccharides as a Choice for Therapeutics
- 7.2 Why Guar Gum?
- 7.2.1 Guar Gum Processing
- 7.3 Synthesis of Guar Gum-based Therapeutics
- 7.3.1 Antihypertensive Drugs
- 7.3.2 Anticancer Drugs
- 7.3.3 Anti-infective Drugs
- 7.3.4 Anti-inflammatory
- 7.4 Different Ways of Giving Drugs Using a Polymer Blend
- 7.4.1 Particulate Level Blends
- 7.4.2 Colloidal Level Blends
- 7.4.3 The Molecular-level Blends
- 7.4.4 Excipients
- 7.4.5 Film Coatings and Oral Films
- 7.4.6 Tablets
- 7.4.7 Capsules
- 7.5 Applications
- 7.5.1 Guar Gum-based Microparticles for Drug Delivery
- 7.5.2 Guar Gum-based Nanoparticles for Drug Delivery
- 7.5.3 Guar Gum-based Nanoparticles as Self-healing, Injectable, and Antibacterial Biomaterials
- 7.5.4 Self-healing Properties
- 7.5.5 Injectable and Antibacterial Properties
- 7.5.6 Guar Gum-based Grafted Systems for Drug Delivery
- 7.5.7 Guar Gum-based Hydrogel Systems for Drug Delivery
- 7.5.8 Guar Gum-based Buccal Film for Drug Delivery
- 7.5.9 Guar Gum-based Tablets for Drug Delivery
- 7.6 Guar Gum-based Microsphere for Delivery of Anticancer Drugs
- 7.7 Toxicity Status of Guar Gum-based Therapeutics
- 7.8 Alternatives to Guar Gum
- 7.9 Conclusion
- Chapter 8 Gellan Gum-based Drug Delivery Carriers
- 8.1 Introduction
- 8.2 Sources and Production of Gellan Gum
- 8.2.1 Factors Affecting Gellan Gum Production
- 8.2.2 Isolation of Gellan Gum from the Culture Broth
- 8.2.3 Purification of Gellan Gum
- 8.3 Chemistry of Gellan Gum
- 8.4 Physicochemical Properties of Gellan Gum
- 8.5 Rationale of Gellan Gum as a Drug Carrier
- 8.6 Chemical Modifications of Gellan Gum for Benefits of Drug Delivery
- 8.6.1 Carboxymethylation
- 8.6.2 Graft-copolymerization
- 8.6.3 Oxidation.
- 8.6.4 Alkylation
- 8.6.5 Gellan-Thioglycolic Acid Conjugate
- 8.7 Gellan Gum-based Drug Delivery Carriers
- 8.7.1 Gellan Gum-based Beads
- 8.7.2 Gellan Microparticles
- 8.7.3 Gellan Pellets
- 8.7.4 Gellan-based In Situ Gel
- 8.7.5 Tablets
- 8.7.6 Hydrogels
- 8.7.7 Micelles
- 8.7.8 Gellan Nanoparticles
- 8.7.9 Gellan as an Emulsion Stabilizer
- 8.7.10 Gellan-based Nanofiber
- 8.8 Conclusion
- Chapter 9 Locust Bean Gum - A Potential Drug Delivery Carrier
- 9.1 Introduction
- 9.2 Locust Bean Gum
- 9.2.1 Manufacture
- 9.2.2 Processing
- 9.2.3 Composition
- 9.2.4 Chemical Structure
- 9.3 Properties of LBG
- 9.3.1 Solubility
- 9.3.2 Viscosity
- 9.3.3 Molecular Weight
- 9.3.4 Hydration Rate
- 9.3.5 Water Adsorption Isotherm
- 9.3.6 Synergistic Gel Formation
- 9.4 Biological Activity of LBG
- 9.5 Biocompatible and Biodegradable Nature of LBG
- 9.6 Drug Delivery Applications
- 9.6.1 Oral Drug Delivery
- 9.6.2 Buccal Drug Delivery
- 9.6.3 Colonic Drug Delivery
- 9.6.4 Topical Drug Delivery
- 9.6.5 Ocular Drug Delivery
- 9.6.6 Inhalable LBG Microparticles
- 9.6.7 Solubility Improvement of Poorly Water-soluble Drugs
- 9.6.8 Tissue Engineering Application of LBG
- 9.7 Conclusions
- Chapter 10 Pectin-based Vehicles for Delivery of Therapeutics
- 10.1 Introduction
- 10.2 Overview of Pectin as a Biomaterial
- 10.3 Variety of Pectin-based Delivery Vehicles
- 10.4 Pectin as a Suitable Mucoadhesive Vehicle
- 10.5 Range of Therapeutics Delivered via Pectin Vehicles
- 10.5.1 Pectin Vehicles for Small Molecular Drug Delivery
- 10.5.2 Pectin Vehicles for Gene Delivery
- 10.6 Therapeutic Applications of Pectin-based Drug Delivery Vehicles
- 10.6.1 Oral Delivery
- 10.6.2 Systemic Delivery
- 10.6.3 Intranasal Delivery
- 10.6.4 Topical Delivery
- 10.6.5 Ocular Delivery.
- 10.6.6 Vaginal Delivery
- 10.7 Clinical Progress
- 10.8 Summary
- 10.9 Challenges and Future Perspectives
- List of Abbreviations
- Conflicts of interest
- Chapter 11 Pullulan in the Delivery of Therapeutics
- 11.1 Introduction and Background
- 11.2 Pullulan as a Drug Carrier
- 11.3 Pullulan Derivatives as Drug Carriers
- 11.4 Pullulan-based Therapeutic Laborers with Bactericidal and Fungicidal Activities
- 11.5 Pullulan-based Anticancer Laborers
- 11.6 Pullulan-based Antioxidant Laborers with Radical Leaching Potentiality
- 11.7 Pullulan-based Therapeutic Laborers with Anti-inflammatory and Immunomodulatory Performance
- 11.8 Pullulan-based Therapeutic Laborers for Bone Illness
- 11.9 Conclusion
- Chapter 12 Carrageenan-based Carriers for Therapeutic Delivery
- 12.1 Introduction
- 12.2 Sources of Carrageenan
- 12.3 Extraction of Carrageenan
- 12.4 Production
- 12.5 Chemical Structure
- 12.6 General Properties
- 12.7 Modification of Carrageenan
- 12.8 Carrageenan-based Carriers
- 12.8.1 Hydrogels
- 12.8.2 Tablets
- 12.8.3 Beads
- 12.8.4 Suppositories
- 12.8.5 Oral Suspensions
- 12.8.6 Pallets
- 12.8.7 Internasal Systems
- 12.8.8 Micro/nanoparticles
- 12.8.9 Wafers
- 12.9 Applications of Carrageenan in Therapeutic Delivery
- 12.9.1 Oral Delivery
- 12.9.2 Opthalmic
- 12.9.3 Nasal Delivery
- 12.9.4 Transdermal
- 12.10 Conclusion
- Chapter 13 Xanthan Gum in Drug Carriers
- 13.1 Introduction
- 13.1.1 History of Xanthan Gum
- 13.1.2 Production
- 13.1.3 Chemical Composition and Structure
- 13.1.4 Physico-chemical Properties
- 13.2 Modifications
- 13.2.1 Carboxymethylation
- 13.2.2 Grafting
- 13.2.3 Phosphorylation
- 13.2.4 Esterification
- 13.2.5 Miscellaneous Modifications
- 13.3 Xanthan Gum for Drug Delivery Applications.
- 13.3.1 Nanoparticles.
- Notes:
- Description based on print version record.
- ISBN:
- 9781839166235
- 1839166231
- 9781839166242
- 183916624X
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.